Silk Road Medical Stock (NASDAQ:SILK), Analyst Ratings, Price Targets, Predictions

The latest price target for Silk Road Medical (NASDAQ: SILK) was reported by JP Morgan on May 1, 2024. The analyst firm set a price target for $21.00 expecting SILK to fall to within 12 months (a possible -0.14% downside). 25 analyst firms have reported ratings in the last year.

The latest analyst rating for Silk Road Medical (NASDAQ: SILK) was provided by JP Morgan, and Silk Road Medical maintained their neutral rating.

The last upgrade for Silk Road Medical Inc happened on March 7, 2024 when Argus Research raised their price target to $24. Argus Research previously had a hold for Silk Road Medical Inc.

The last downgrade for Silk Road Medical Inc happened on October 11, 2023 when CL King changed their price target from N/A to N/A for Silk Road Medical Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Silk Road Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Silk Road Medical was filed on May 1, 2024 so you should expect the next rating to be made available sometime around May 1, 2025.

While ratings are subjective and will change, the latest Silk Road Medical (SILK) rating was a maintained with a price target of $19.00 to $21.00. The current price Silk Road Medical (SILK) is trading at is $21.03, which is out of the analyst’s predicted range.